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Nijmegen Breakage Syndrome 
fibroblasts and iPSCs: cellular 
models for uncovering disease-
associated signaling pathways and 
establishing a screening platform 
for anti-oxidants
Barbara Mlody  1, Wasco Wruck2, Soraia Martins2, Karl Sperling3 & James Adjaye2
Nijmegen Breakage Syndrome (NBS) is associated with cancer predisposition, premature aging, 
immune deficiency, microcephaly and is caused by mutations in the gene coding for NIBRIN (NBN) 
which is involved in DNA damage repair. Dermal-derived fibroblasts from NBS patients were 
reprogrammed into induced pluripotent stem cells (iPSCs) in order to bypass premature senescence. 
The influence of antioxidants on intracellular levels of ROS and DNA damage were screened and it was 
found that EDHB-an activator of the hypoxia pathway, decreased DNA damage in the presence of high 
oxidative stress. Furthermore, NBS fibroblasts but not NBS-iPSCs were found to be more susceptible 
to the induction of DNA damage than their healthy counterparts. Global transcriptome analysis 
comparing NBS to healthy fibroblasts and NBS-iPSCs to embryonic stem cells revealed regulation of 
P53 in NBS fibroblasts and NBS-iPSCs. Cell cycle related genes were down-regulated in NBS fibroblasts. 
Furthermore, oxidative phosphorylation was down-regulated and glycolysis up-regulated specifically 
in NBS-iPSCs compared to embryonic stem cells. Our study demonstrates the utility of NBS-iPSCs as 
a screening platform for anti-oxidants capable of suppressing DNA damage and a cellular model for 
studying NBN de-regulation in cancer and microcephaly.
Nijmegen Breakage Syndrome (NBS) is a rare autosomal recessive genetic disorder, first described 1981 in 
Nijmegen, the Netherlands1. Characteristics of NBS include genomic instability (resulting in early onset of malig-
nancies), premature aging, microcephaly and other growth retardations, immune deficiency, impaired puberty 
and infertility in females. The consequence of these manifestations is a severe decrease in average life span, caused 
by cancer or infection of the respiratory and urinary tracts2.
On a molecular basis, NBS is caused by mutations in the gene coding for NIBRIN (NBN) which is involved in 
DNA damage repair3. Mutated versions of NBN cause accumulation of unrepaired DNA damage leading to cell 
cycle arrest, apoptosis4 or accumulation of genomic point mutations and aberrations introduced by misregulated 
DNA repair5. Several cases of NBS with a variety of mutations in NBN exist but over 90% of the patients carry a 5 
base pair deletion (657del5) within the NBN exon 66.
This hypomorphic mutation leads to a truncated 26 kD amino-terminal protein and a 70 kD carboxy-terminal 
protein due to alternative translation from a cryptic start site upstream of the deletion7. Mice Nbn null muta-
tions are embryonic lethal and cells expressing only the truncated p26kD NBN fragment containing the FHA 
and the first BRCT domain, were nonviable7. The new splice form, p70 retains sufficient functionality to ensure 
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survival by binding to MRE11 and ATM, which are essential components of DNA damage response8. The 
MRE11-RAD50-NBN (MRN) complex binds directly to DNA double-strand breaks (DSBs) and is involved 
in repair and signaling for homologous recombination (HR), non-homologous end joining (NHEJ) and 
microhomology-mediated end joining (MMEJ). Additionally, NBN is involved in telomere maintenance and 
therefore plays a role in the aging process8.
Recent works indicate that NBN influences the repair pathway choice via 53BP1, which can shift the error-free 
HR-directed repair to the more error-prone NHEJ and MMEJ9. Apart from replication errors, mutagens and 
other external influences, endogenously, DNA damage is mostly caused by reactive oxygen species (ROS), which 
are byproducts of the respiratory chain reaction10. Cells counteract ROS by antioxidant production and enzymatic 
removal but ROS also have cellular signaling functions which must be maintained in a controlled balance11.One 
strategy to minimize endogenous ROS levels is to regulate mitochondrial respiration, which plays a special role 
in stem cells.
Stem cell mitochondrial morphology is immature, rounded and with under-developed cristae. Consequently, 
they depend heavily on glycolysis for their ATP supply12. When cells differentiate and increase respiration, mito-
chondrial mass increases, their morphology then shifts to more matured and elongated tubular forms, with more 
defined cristae and increased mtDNA copy numbers12.
When somatic cells are reprogrammed into induced pluripotent stem cells (iPSCs), they depend predomi-
nantly on glycolysis and their mitochondria become rejuvenated and transformed back to the immature form13.
A key element in the reprogramming of metabolism is the HIF1-alpha pathway, which not only reacts in 
response to hypoxia, but also induces a shift from oxidative phosphorylation to glycolysis14. We have reported 
this “metabolic reprogramming” as an essential step in iPSC-generation, which precedes the activation of 
pluripotency-associated genes like OCT4 and NANOG15.
The aim of this study was to use our previously published iPSC-based cellular model system for NBS and 
provide a screening platform for antioxidants capable of modulating genome stability. NBS-iPSCs may overcome 
several problems associated with NBS research such as: i) small patient numbers, ii) cell cultures limited to fibro-
blasts and lymphocytes, iii) premature senescence in cell culture due to high levels of ROS, iv) discovery of new 
NBS molecular mechanisms and v) provision of new and therapeutically relevant concepts.
There are several diseases like NBS which derive from mutated genes in repair pathways, examples of 
these include Fanconi Anemia (FA)16, Ligase IV (LIG4) syndrome17,Bloom syndrome18,NBS-like disorder19, 
Ataxia-Telangiectasia-Like Disorder (ATLD)20, Nonhomologous end-joining factor 1 (NHEJ1) syndrome21 and 
Seckel syndrome22.
Our group recently published a study on modeling NBS by reprogramming23. Reprogrammed cells from 
patients with similar diseases like FA have been reported, though they could only be reprogrammed after genetic 
correction or with the aid of antioxidants24. In a study of patients with Cockayne syndrome (CS), a mutation in 
the repair pathway gene ERCC6 did not impair genetic reprogramming but exhibited elevated cell death rates and 
ROS production25. As NBS cells are hypersensitive to DNA damage26, ROS may be detrimental to them under 
physiological conditions. Thus, it was hypothesized that antioxidants or the induction of pluripotency in NBS 
fibroblasts might suppress and maybe bypass ROS-mediated genome instability.
Microcephaly is a significant physical characteristic of NBS which can also be found in FA, LIG4 and NHEJ1 
syndromes16, 20, 21. With recent cases in microcephaly which coincided with infections of the Zika virus27, 
NBS-iPSCs and iPSC-derived neurons could serve as an excellent comparative model to study NBN-deregulation 
and associated molecular mechanisms underlying the onset of microcephaly.
In this study we present NBS fibroblasts and iPSCs as a screening platform for anti-oxidants and a model for 
studying NBN de-regulation in cancer and microcephaly. The screen for antioxidants capable of counteracting 
intracellular levels of ROS and DNA damage identified Ethyl-3,4-dihydroxybenzoate (EDHB) - an activator of 
the hypoxia pathway – as most potent antagonist of DNA damage in the presence of high oxidative stress in 
our NBS-model. Another finding was the higher susceptibility of NBS fibroblasts to induction of DNA dam-
age compared to NBS-iPSCs. Furthermore, we found de-regulation of P53 in NBS fibroblasts and NBS-iPSCs, 
down-regulation of Cell cycle in NBS fibroblasts and down-regulation of oxidative phosphorylation and 
up-regulation of glycolysis in NBS-iPSCs compared to healthy embryonic stem cells.
Results
Roadblocks in reprogramming of NBS fibroblasts. Reprogramming of somatic cells towards pluripo-
tent stem cells (PSCs) was reported to be negatively affected when P53 was activated28. Given the nature of NBS, 
which includes genomic instability and premature senescence, both of which are features known to lead to P53 
activation29, thus, hurdles for the reprogramming process were anticipated. To address these, we attempted repro-
gramming dermal fibroblast primary cultures from eight (8) clinically diagnosed patients with NBS.
Of the 8 NBS fibroblast lines (Table 1), 3 lines could not be cultured past passage 6 and were lost due to pre-
mature senescence. Four (4) lines were infected with retroviral reprogramming cocktail (O/S/K/M) but exhib-
ited low infection efficiency (determined by O/S/K/M immuno-staining), senescence (by morphology), hardly 
showed changes in morphology (negative indicator for reprogramming) and did not yield any iPSC colonies (data 
not shown).
As previously reported and characterized, only one of the four NBS fibroblast cell lines (NBS-8) sub-
jected to the reprogramming process was successful23, 30. This shows that fibroblasts from NBS patients can be 
reprogrammed to pluripotency despite genomic instability and premature senescence30. Sanger-sequencing 
of NBN exon 6 and Western Blotting confirmed the heterozygous mutation for 657del5 in NBS-8 fibroblasts 
(Supplementary Figure S1) and in the NBS-8-iPS cells (Supplementary Figure S2). As the 657del5 mutation leads 
to a truncation of NBN on the protein level (wt: 95 kDa; 657del5: 70 kDa), we detected NBN by western blot. 
Full-length NBN was not present in any of the NBS fibroblasts including NBS-8 and the NBS-iPSCs30.
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In vitro cultivation may introduce stress to the cells which may also elevate DNA double-strand breaks events. 
Accumulation of unrepaired damage DNA leads to the activation of P53, which is a known roadblock of induc-
tion of pluripotency as a result of cell cycle arrest, senescence or apoptosis31. Table 1 shows that the reprogramma-
ble cell line NBS8 is heterozygous while the other cell lines are homozygous. It is probable that the homozygous 
nature of the mutated NBS gene increases the level of unrepaired damaged DNA hence drastically reducing the 
efficiency of inducing pluripotency. To examine this further, we performed transcriptome analysis of primary 
NBS fibroblasts cell cultures (1, 3, 5, 7 and 8).
Ingenuity® Pathway Analysis (IPA) was used to predict the status of transcription factors (TFs) using a list 
of differentially regulated genes between NBS and normal fibroblasts (Table 2). In the IPA results in Table 2 the 
fold change was determined by the expression data of the transcription factor itself but this can be different 
from the data inferred from the expression data of the de-regulated genes. The most significant, activated TF 
was P53 (TP53), well known to negatively interfere with reprogramming efficiency. We also found that the P53 
pathway was significantly enriched in the transcriptomic analysis of the NBS fibroblasts (see “NBS-iPSCs as a 
model for studying molecular mechanisms associated with impaired DNA repair”). Among the most significant 
down-regulated or inactivated TFs was MYCN, which is known as transcriptional regulator in pluripotent stem 
cells32. This could also be a roadblock to reprogramming, as cells are required to proliferate continually during 
this process.
Which genes/factors contribute to bypassing of cell cycle arrest, senescence or apoptosis. To 
understand which mechanisms possibly enabled NBS fibroblasts to achieve pluripotency and therefore overcome 
cellular senescence, we compared transcriptomic data between NBS-8 fibs, NBS-8-iPSCs and hESCs. By identi-
fication of the overlaps for expressed genes (determined by expression p value < 0.01) we found 2642 genes to 
be commonly expressed in NBS-iPSCs and hESCs, but not in NBS fibroblasts (Fig. 1). This subset of genes may 
contain the distinct profile enabling NBS fibroblasts to reach pluripotency and therefore rejuvenation. We further 
analyzed the subset in an annotation database. Among the most over-represented results we found MAPK sign-
aling pathway and genes that were specifically expressed in the brain (Fig. 1c). The MAPK signaling pathway is 
regulated by OCT4 and plays an important role in pluripotency and self-renewal33.
Cell line 
[NBS #] Gender
Passage 
[#]
Premature 
senescence
NBN (657del5) 
Mutation
1 male 16 No homozygous
2 male 5 Yes homozygous
3 female 8 No homozygous
4 female 14 Yes homozygous
5 female 4 No homozygous
6 female 10 Yes homozygous
7 male 10 No homozygous
8 male 3 No heterozygous
Table 1. Fibroblasts lines from NBS patients and their behavior in reprogramming. n/a: not available; #: 
number.
Transcription 
Regulator
Fold Change 
(Array data)
Predicted 
Activation State
Regulation 
z-score
Number of 
target molecules
TP53 1.48 Activated 4.32 175
CDKN2A 1.05 Activated 3.93 46
SMARCA4 −1.49 Activated 3.70 34
SMARCE1 1.24 Activated 2.45 6
TCF3 2.02 Activated 2.39 35
Rb (group) n/a Activated 2.26 14
GATA1 −1.09 Activated 2.24 11
TP63 −1.00 Activated 2.23 27
GLI3 1.65 Activated 2.11 4
SMAD7 −1.63 Inhibited −2.13 16
SREBF1 −1.26 Inhibited −2.31 22
RXRA 1.08 Inhibited −2.46 17
SREBF2 1.16 Inhibited −2.48 15
E2F1 1.36 Inhibited −2.60 63
TBX2 −1.72 Inhibited −2.77 24
MYCN −1.07 Inhibited −4.41 33
Table 2. Regulation changes in transcription factors in NBS fibroblasts (Ingenuity® Prediction Tool).
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Global transcriptome analysis of NBS-iPSCs. Global transcriptome analysis with NBS fibroblasts and 
NBS-iPSCs was performed to identify the problems interfering with reprogramming in the cell lines 1,3,5,7, 
determine NBS phenotypes or compensatory mechanisms in NBS-iPSCs derived from NBS-8 fibroblasts. In the 
cluster dendrogram (Fig. 2a), fibroblasts from NBS patients clearly clustered as a group and differed from normal 
fibroblasts, indicating a common transcriptional phenotype distinctive for NBS. Transcriptomes from NBS-iPSCs 
clustered closer to hESCs than to other fibroblasts-derived iPSCs (Fig. 2b). But, the parental fibroblast line NBS-
8, clustered more distinct to the other fibroblasts. The pronounced gap in clustering between NBS-8-Fib-P8 and 
NBS-8-Fib-P15 indicates acquisition of mutations or aberrations since they only differ in passage number.
Figure 1. Statistics of Venn diagram analysis among NBS fibroblasts, NBS iPSCs and hESCs. The overlap of 
significantly expressed genes (detection p value < 0.01) in (a) Fibroblasts comparing the averaged group of NBS 
with unaffected cell lines and in (b) NBS fibroblasts versus NBS-iPSCs and unaffected hESCs. (c) Annotations 
for genes commonly expressed in NBS-iPSCs and hESCs but not NBS fibroblasts resulting from functional 
annotation analysis via the DAVID web tool. The output of the DAVID analysis was condensed to the count of 
genes annotated with the indicated category, p-value and Benjamini-Hochberg-correction for multiple-testing as 
calculated based on the Fisher-exact test.
www.nature.com/scientificreports/
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After selecting genes that were significantly de-regulated (p value < 0.05; fold change > 1.5) between the 
groups of NBS and normal fibroblasts, the list was subjected to “DAVID Annotation Tools”34 to identify path-
ways which were most affected by mutated NBN (Fig. 3a). The same procedure was performed for the analysis 
of NBS-iPSCs in comparison with hESCs (Fig. 3b). There were different regulatory changes in both groups of 
analyses (NBS fibroblasts and NBS-8-iPSCs), but there was also overlap of pathways, indicating NBS specific traits 
in cell cycle and cancer. Apoptosis and P53, two of the safeguard mechanisms against cancer, were predominantly 
de-regulated in NBS fibroblasts than pluripotent NBS cells while Mismatch repair, another safeguard mechanism 
against cancer, was predominantly de-regulated in pluripotent NBS cells. Mismatch repair is illustrated in more 
detail in the heatmap in Fig. 3c (color bars: blue = NBS, red = healthy). In Cell cycle we observed a shift from 
down-regulation to equally balanced (Fig. 3a,b,d,e).
Interestingly, in NBS-iPSCs, the Glycolysis-pathway was significantly enriched. Most enzymes involved in 
glycolysis, including phosphofructokinase, muscle (PFKM, 2-fold) which catalyzes the rate-limiting step, were at 
least 1.5-fold up-regulated (Supplementary Figure S3). On the other hand, Fructose-1,6-bisphosphatase 1 (FBP1), 
a gluconeogenesis regulatory enzyme, was significantly down-regulated (2.6-fold). As previously reported, hESCs 
derive their energy from glycolysis rather than OXPHOS and have immature mitochondria13, 35. It was also 
observed that cells acquire the same metabolic profile during the reprogramming process13, 35. NBS-iPSCs in this 
case, depended even stronger on glycolysis than other PSCs.
Figure 2. Global transcriptomic comparison of NBS fibroblasts and iPSCs to healthy controls. (a) Hierarchical 
cluster analysis depicting the distance of control (BJ, HFF1, NFH13) and patient (NBS-1, -3, -5, -7) fibroblasts 
global mRNA (Illumina 8-chip). (b) Hierarchical cluster analysis of total mRNA depicting the distance of 
control (BJ-Fib, HFF1-Fib) and patient (NBS8-Fib, passage number 8 and 15) fibroblasts, plus control (H1, H9, 
vHFF-iPS, vBJ-iPS) and patient (vNBS8-iPS, clone 1 and 2) pluripotent stem cells (Illumina 12-chip).
www.nature.com/scientificreports/
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Figure 3. Functional transcriptomics study of NBS fibroblasts and iPSCs. Significantly de-regulated genes 
(differential p value < 0.05; fold-ratio > 1.5) between control and NBS-patient cells were analyzed by DAVID 
functional annotation tool (https://david.ncifcrf.gov/). The top 10 significantly (p value < 0.05) de-regulated 
KEGG pathways (http://www.genome.jp/kegg/pathway.html) are represented in the figure, numbers of 
significantly up-regulated genes are shown in red and down-regulated genes in green. (a) comparison between 
control (BJ, HFF1) and patient (NBS-1, -3, -5, -7) fibroblasts (b) comparison between control (H1, H9) and 
patient (vNBS8-iPS, clone 1 and 2) pluripotent stem cells. (*) p value of pathway > 0.05. The reprogramming 
procedure induced a shift of the Cell cycle pathway from down-regulated to nearly balanced. Furthermore, 
strong down-regulation of the Mismatch repair pathway was found in NBS-iPSCs. Cluster analysis and 
heatmaps of these de-regulated pathways are shown in (c–e): (c) depicts the Mismatch repair in NBS-iPSCs, (d) 
the Cell cycle in NBS fibroblasts and (e) the Cell cycle in NBS-iPSCs (Color bars: blue NBS, red control).
www.nature.com/scientificreports/
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NBS-iPSCs as a model for studying molecular mechanisms associated with impaired DNA 
repair. In line with the known predisposition of NBS patients to cancer, we found Pathways in cancer as the 
most enriched pathway in NBS-fibroblasts compared to healthy fibroblasts as well as in NBS-iPSCs compared 
to embryonic stem cells via DAVID analysis34 (Fig. 3a,b). With further cancer-related pathways, Cell cycle was 
found to be enriched in NBS-fibroblasts and NBS-iPSCs, while Apoptosis and p53 signaling were only enriched 
in NBS-fibroblasts. To further explore the relevance of the KEGG pathways in cancer36 we performed a fur-
ther DAVID analysis with the genes annotated with that pathway in differentially expressed genes in NBS-iPSCs 
compared to embryonic stem cells and this way could refine the functional annotation of the pathways in cancer 
(suppl. Table. S2). As expected numerous specific cancer types such as lung cancer and Melanoma are anno-
tated with these genes but also pathways related to NBS emerge. Cell cycle (Supplementary Figure S4) and p53 
signaling (Supplementary Figure S5) are known to be impaired by NBS and are described in more detail in the 
section “Establishing the antioxidant screening platform”. The cluster analyses in Fig. 3 (c–e) and Supplementary 
Figure S6–S8 additionally provide a more detailed view of the dysregulation of dedicated genes in the pathways 
Mismatch repair (Fig. 3c), Cell cycle (Fig. 3d,e), Glycolysis (Supplementary Figure S6), Oxidative phosphoryla-
tion (Supplementary Figure S7) and p53 signaling (Supplementary Figure S8) between NBS and healthy states. 
The Mismatch repair (Fig. 3c) was predominantly down-regulated (6 of 7 genes) in the NBS-iPSCs. Impairment 
of Mismatch repair is associated with predisposition to cancer37. Cell cycle appears to shift from predomi-
nantly down-regulation (36 of 41 genes) in the NBS-fibroblasts to equal balance (16 genes down- and 12 genes 
up-regulated) in the NBS-iPSCs. Another shift along with the reprogramming took place from Oxidative phos-
phorylation in the NBS-fibroblasts to Glycolysis in the NBS-iPSCs (Supplementary Figures S6 and S7). This effect 
may have been induced by p53 down-regulation during reprogramming38 and showed similarities to the Warburg 
effect in cancer cells which produced energy by Glycolysis39. In line with our previous publication23, we found that 
essential genes such as TP53I3 in the p53 pathway shifted from up- to down-regulation during reprogramming. 
Supplementary Figure S8 depicts the p53 signaling in a comparison between NBS/WT PSCs and fibroblasts and 
demonstrates differences (including more down-regulation of the genes P53 and TP53I3) in the only NBS line 
which could be reprogrammed (NBS8) compared to the other NBS lines.
Establishing the antioxidant screening platform. During cultivation of PSCs, which was performed 
at 5% oxygen levels, a temporary switch (12 h) to ambient (21%) oxygen resulted in apoptosis of NBS-iPSCs, but 
HFF1-iPSCs and hESCs were unaffected. We tested the effect of low (5%) and high (21%) oxygen quantitatively, 
by measuring gamma-H2AX, a marker for DNA double strand breaks in the presence or absence of the radiomi-
metic, Bleomycin. The result showed that low oxygen conditions greatly decreased the DNA damage under the 
influence of the mutagen. In addition, NBS Fibroblasts were more sensitive to DNA damage by mutagens than 
normal fibroblasts and the effect of low oxygen was less pronounced (Fig. 4a). NBS-iPSCs were then screened for 
various types of antioxidants to mimic or enhance the effect of low oxygen. The test measuring intracellular ROS 
levels revealed promising candidates to relieve NBS cells of oxidative stress, of which disulfiram (DSF) and EDHB 
were the most pronounced (Fig. 4b).
EDHB is utilized as a substrate analog and competitive inhibitor of prolyl 4-hydroxylases leading to specific 
inhibition of collagen synthesis40 and to activation of the hypoxia inducible factor (HIF)41. We tested the effect of 
EDHB on intracellular ROS levels under stress conditions by supplementation with hydrogen peroxide (H2O2). 
EDHB decreased normal ROS levels and greatly decreased intracellular ROS levels in the presence of H2O2 in 
fibroblasts and PSCs (Fig. 4c,d). Interestingly, in fibroblasts, ROS levels were higher in EDHB treatment alone 
compared to treatment with EDHB plus hydrogen peroxide while in PSCs EDHB alone was lower than that of 
EDHB plus hydrogen peroxide treatment group. This effect was even more pronounced in NBS cells and needs 
further exploration. One possible explanation would be a change in ROS levels due to the shift in energy supply 
from oxidative phosphorylation to glycolysis along with the reprogramming which was described in the above 
paragraph “Global transcriptome analysis of NBS-iPSCs”.
The effect of EDHB on DNA damage under stress conditions was also tested by supplementation with hydro-
gen peroxide or the radiomimetic Bleomycin. In fibroblasts, EDHB greatly decreased the DNA damage induced 
by hydrogen peroxide and moderately decreased the DNA damage caused by Bleomycin (Fig. 4e). In PSCs, EDHB 
decreased the DNA damage induced by H2O2 by 50%, but did not alter the DNA damage caused by Bleomycin 
(Fig. 4f). In addition, the same effects of EDHB, H2O2 and Bleomycin on DNA damage in PSCs could also be 
detected using western blotting (Fig. 4h).
As cells from patients with NBS are known to be affected by abnormal cell cycle checkpoints, e.g. fail-
ure of intra-S checkpoint after radiation42, we determined the influence of DNA damage (administered by 
Bleomycin-treatment) and HIF-Pathway activation by EDHB on the status of CHEK1 and CHEK2, which are 
usually phosphorylated upon activation43. CHEK1 (S345) phosphorylation is mostly facilitated by ATR and 
required for the G2/M DNA damage checkpoint44, 45. Upon DNA damage, CHEK1 becomes activated, it phos-
phorylates and inhibits CDC25C, thereby preventing activation of the cyclin B/CDK2 complex responsible for 
mitotic entry46. HFF1 cells only showed a slight increase in P-CHEK1 after treatment with bleomycin, but NBS-8 
fibroblasts on the other hand exhibited CHEK1 activation without any treatment (Fig. 4g). This was decreased, 
but not eliminated upon treatment with EDHB. Bleomycin did not cause stronger activation than in control and 
this was not challenged by EDHB treatment. Interestingly, the supplementation with H2O2 completely dimin-
ished CHEK1 phosphorylation but not in the presence of EDHB.NBS iPSCs were found to have slightly higher 
base-level of phosphorylated CHEK1 in comparison to unaffected PSCs (H1, Fig. 4h). Treatment with EDHB 
reduced P-CHEK1 levels in NBS iPSCs under radiomimetic stress (Bleomycin) conditions, compared to the 
control.
CHEK2 is known to be phosphorylated (T68) and activated in an ATM-dependent manner in response to ion-
izing radiation47. In our NBS-context it is essential that the MRN complex regulates the activation of ATM43, 48 and 
www.nature.com/scientificreports/
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Figure 4. Response of NBS cells to oxidative stress and antioxidants. (a) The abundance of DNA damage 
measured by FACS-based detection of the DNA double-strand marker gamma-H2AX in HFF1 and NBS8 
fibroblasts. DNA damage was induced by 30 µg/ml Bleomycin and compared under ambient (21%) and 
physiological (5%) oxygen concentrations. (b) NBS8-iPSCs were treated with either H2O2, several compounds 
known to influence DNA repair and ROS levels, or both. Internal ROS levels were then measured by FACS-
based detection of the fluorescent ROS marker DCF-DA. The results were normalized to the untreated or 
peroxide-alone treated conditions respectively. (c) The influence of EDHB on internal ROS levels was tested 
on control (HFF1) and patient fibroblasts (NBS5, NBS8). The cells were either treated with EDHB alone or in 
combination with H2O2 to stimulate oxidative stress conditions. (d) Same experiment as in (c), but comparing 
control (hESCs) and patient (NBS-iPSCs) pluripotent stem cells. (e) The influence of EDHB on DNA damage 
(by detection of gamma-H2AX) was tested on control (HFF1) and patient fibroblasts (NBS5, NBS8). The 
cells were either treated with EDHB alone, in combination with H2O2 to stimulate oxidative stress conditions, 
or in combination with Bleomycin to stimulate mutagenic stress conditions. (f) Same experiment as in (e) 
but comparing control (hESCs) and patient (NBS-iPSCs) pluripotent stem cells. Bars indicate SD between 
independent experiments (n = 3). (g,h) Influence of DNA damage and EDHB on phosphorylation of DNA 
damage signaling proteins. Cells were treated with EDHB (antioxidant and inducer of HIFpathway), hydrogen 
peroxide (H2O2) and radiomimetic bleomycin (Bleo). (g) Immunofluorescent detection of phosphorylated 
signaling proteins in fibroblasts (HFF1, NBS-8) after SDS-PAGE. (h) Immunofluorescent detection of 
phosphorylated signaling proteins in hESCs (H1) and NBS-8-iPSCs (N1) after SDS-PAGE. Each lane of 
b-Actin corresponds to the lanes directly above and b-Actin is always unphosphorylated. For the sake of better 
readability western blots were cropped.
www.nature.com/scientificreports/
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acts upstream as well as downstream of ATM49. Activated CHEK2 phosphorylates P53 at serine-2050 CDC25A at 
serine-12351 and CDC25C at serine-216 thus, contributing to the G1/S, S, and G2/M checkpoints respectively52. 
In HFF1 cells treated with H2O2, CHEK2 became phosphorylated and this increased after combined application 
of H2O2 and EDHB (Fig. 4g). The same effect was observed in NBS-8 fibroblasts. Bleomycin did not activate 
CHEK2 in HFF1 cells, but the activation was strong in NBS-8 cells. Here, a low base-level of P-CHEK2 in PSCs 
was observed (Fig. 4h). Upon DNA damage, P-CHEK2 activation was significantly high in NBS-iPSCs (N1) but 
decreased after treatment with EDHB (Fig. 4h).
Previous experiments using FACS analysis revealed that EDHB can decrease DNA damage caused by H2O2 
in fibroblasts and iPSCs, but only moderately reduce the damage in fibroblasts caused by bleomycin (data not 
shown). Western Blot analysis of gamma-H2AX after treating hESCs and NBS-8-iPSCs with H2O2 and bleomycin 
confirmed these measurements (Fig. 4h). It also showed that the application of H2O2 can indeed result in DSBs 
as indicated by the increased detection of gamma-H2AX. But it is important to keep in mind that in comparison 
(y-H2AX measurement, (Fig. 4h), H2O2 induced approx. the same level of DNA damage in hESCs as bleomycin, 
but 2-fold lower DNA damage in fibroblasts than in ESCs. Here, DNA damage was induced by oxidative stress in 
the form of H2O2 and by the DSB-inducer bleomycin (Fig. 4g,h).
This study shows, that in HFF1 cells, P53 S15 phosphorylation was observed after treatment with bleomycin, 
but not after H2O2 administration. In addition, the level of induction was lowered by addition of EDHB in the 
bleomycin treatment. In NBS-8 cells, the same effect was observed, but the P53 activation by bleomycin was lower 
and was almost abolished after EDHB treatment (Fig. 4g). In hESCs and NBS-8-iPSCs P53 was only phosphoryl-
ated at S15 after bleomycin treatment as well. But here, P-P53 was higher in NBS-8-iPSCs and EDHB treatment 
did not show a clear effect (Fig. 4h).
ATR is activated by ssDNA that result at a later stage in homologous recombination repair (HRR), or result 
from stalled replication forks. In NBS, repair from HR is impaired, so ATR signaling is rather activated by stalled 
replication forks. In NBS-8 cells, phosphorylated ATM exhibited a similar level without or after treatment with 
H2O2 or bleomycin (Fig. 4g). EDHB on the other hand increased the signal in cells treated with H2O2 (oxidative 
stress) and decreased the signal in cells treated with bleomycin (DSB inducer). Control cells, HFF1, exhibited 
lower basal levels of P-ATM than in NBS-8 cells but got strongly activated after H2O2 and bleomycin treatment. 
EDHB decreased the ATM activation by bleomycin as well. In contrast to ATM, ATR was not activated in HFF1 
and NBS-8 cells by bleomycin. It was phosphorylated after treatment with EDHB or H2O2 in HFF1 cells, but not 
in NBS-8 cells. Here it only became activated after treatment with H2O2 and EDHB together. Comparison of ATM 
activation with activation of its target CHEK2, did not show the expected similar expression level in the western 
blot, neither did CHEK1 as target of ATM.
Here, BRCA1 S1524 phosphorylation appeared on a similar level of activation as ATR in NBS-8 cells, but 
different in HFF1 and also different in both cases in comparison to ATM (Fig. 4g). In detail, BRCA1 was slightly 
activated by H2O2 and bleomycin in HFF1 cells with no difference after addition of EDHB in any case. Again, 
there was a high level of phosphorylated protein in the control in NBS-8 cells, which was only further raised after 
treatment with H2O2 and EDHB. EDHB alone, H2O2 alone, bleomycin alone and bleomycin plus EDHB did show 
a similar expression of P-BRCA1, which was lower than in control.
The important finding here is the ability of EDHB to decrease the amount of DSBs caused by oxidative 
stress (administered by H2O2). EDHB showed a reduction of P-CHEK1 and P-CHEK2 in hESCs and iPSCs 
after bleomycin treatment, and an induction of P-CHEK1 and P-CHEK2 in fibroblasts after treatment of H2O2. 
Interestingly, the important tumor suppressor TP53 was less activated in NBS-8 fibroblasts as in control cells 
(HFF1) and exhibited an even lower signal after treatment with bleomycin.
The pattern in activation of P53, CHEK1 and CHEK2 is similar, but not identical in NBS-8 fibroblasts and 
iPSCs and differs in comparison to their healthy counterparts. The most prominent difference is the response 
of CHEK1 to EDHB in NBS-8 fibroblasts in comparison to NBS-8-iPSCs (activated in response to H2O2 only in 
the presence of EDHB). Furthermore, the relative activation of CHEK2 to bleomycin is a lot stronger in NBS-8 
fibroblasts compared to iPSCs.
Discussion
The DNA damage sensing NBN is an adapter protein which can bind to a variety of other DNA signaling and 
repair proteins particularly ATM, which is a kinase that amplifies and transduces the DNA damage signal53. The 
657del5 mutation in NBN results in a truncated protein where one specific functional domain (FHA-BRCT) 
is missing. This domain is also a common motif within other DNA repair signaling proteins54. DNA repair 
mechanisms especially those of repair pathway decisions are still not fully understood. NBS-iPSCs and their 
differentiated descendants could therefore serve as a good model to study DNA repair and cell fate after DNA 
damage. This could aid in elucidating the mechanisms underlying the disease. NBS-iPSCs can also provide a 
screening system for treatments which might increase the life span and quality of life of patients with NBS and 
similar diseases like Fanconi Anemia (FA), Ligase IV (LIG4) syndrome, Bloom syndrome, NBS-like disorder, 
ataxia-telangiectasia-like disorder (ATLD), Nonhomologous end-joining factor 1 (NHEJ1) syndrome and Seckel 
syndrome, which all derive from mutated genes in repair pathways55, 56. In a recent publication, we modeled and 
characterized NBS by reprogramming23. Reprogrammed cells from patients with similar diseases like FA have 
been reported, though this can be done only after genetic correction or with the aid of antioxidants24. In another 
study, a mutation in the repair pathway gene ERCC6 did not prevent genetic reprogramming but exhibited ele-
vated cell death rates and ROS production25.
Our cellular NBS model was based on fibroblasts from NBS patients reprogrammed into iPSCs, using retro-
viral transduction of OCT4, SOX2, KLF4 and C-MYC. Further, by employing somatic cells and iPSCs of NBS, 
global transcriptome analysis was performed, to identify new phenotypes and changes in the signaling network of 
NBS cells compared to normal cells. In addition, the influence of oxidative stress, radiomimetics and antioxidants 
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was tested on the genomic integrity of NBS cells before and after reprogramming. Comparative transcriptome 
and associated pathway analyses revealed that, (a) NBS fibroblasts have a higher impact on cell cycle regulation, 
apoptosis and P53 signaling than normal fibroblasts (b) NBS-iPSCs and normal hESCs presented de-regulated 
genes and pathways associated with DNA replication, glycolysis, pyrimidine, fructose and mannose metabo-
lism as well as DNA repair related pathways. Notably, these pathways can be connected to ROS homeostasis. 
Comparative tests based on sensitivity towards oxidative stress and DNA damaging agents such as hydrogen per-
oxide and Bleomycin, revealed that NBS-iPSCs and NBS-fibroblasts compared to normal fibroblasts were highly 
sensitive to DSB inducer Bleomycin and oxidative stress induced by exogenous hydrogen peroxide. Interestingly, 
DNA damage from hydrogen peroxide was efficiently relieved by addition of EDHB, an inducer of the hypoxia 
(HIF) pathway. The results indicate that NBS-iPSCs can serve as an excellent model to study NBS and screen for 
antioxidants in vitro.
NBS is a disease of premature aging resulting from the genomic instability caused by the NBN mutation 
which leads to hurdles in the reprogramming process. Activation of P53 is especially known to restrain repro-
gramming28. We observed that P53, a known tumor-suppressor gene, was activated in NBS fibroblasts, result-
ing in increased senescence in the NBS cell cultures and had extremely low reprogramming efficiency. Once 
reprogrammed, the cells maintained pluripotency and proliferated like normal hPSCs. NBS-iPSCs may protect 
themselves from oxidative stress and ROS-induced DNA damage by increased glycolysis which was up-regulated 
in comparison to hESCs. In previous studies, hESCs were found to have immature mitochondria and depended 
heavily on glycolysis13, 15, 35, 57. This bias towards glycolysis might be related to the down regulation of P53, 
increased stress in the NBS iPSCs and hence increased glycolytic lactate production for survival. Furthermore, 
it is known that P53 promotes oxidative phosphorylation38, thus, reduced P53 results in reduced oxidative 
phosphorylation.
Also, PSCs are known to ensure genomic integrity through enhanced apoptosis induction and increased anti-
oxidant defense, contributing to protection against DNA damage58. The finding that antioxidants, particularly 
EDHB, improved genomic stability of NBS-iPSCs can improve reprogramming of additional NBS fibroblasts and 
other diseases like NBS which derive from mutated genes in DNA repair pathways, examples include, Fanconi 
Anemia (FA)16, Ligase IV (LIG4) syndrome17, Bloom syndrome18, NBS-like disorder19, Ataxia-Telangiectasia-Like 
Disorder (ATLD)20, Nonhomologous end-joining factor 1 (NHEJ1) syndrome21 and Seckel Syndrome22.
EDHB was used in another study to protect cells from hypoxia-mediated oxidative damage59. With EDHB 
known as an activator of the HIF pathway, these results point to a reduction of ROS-induced DNA damage and 
subsequent relief of the impaired DNA damage response as the cause for genomic stabilization.
DNA damage response mediated by the MRN complex, ATM/ATR, P53, CHEK1 and CHEK2 are crucial 
in early development of most types of cancer60. Although the role of this core network in relation to DNA dam-
age, cancer and pluripotency has been widely investigated31, 43, several mechanisms in early oncogenesis remain 
unclear.
In this study, we have demonstrated that our model of fibroblasts and iPSCs derived from NBS patients besides 
the study of NBS itself which is associated with microcephaly, premature aging and growth retardation provides 
the environment for a detailed study of oncogenic mechanisms. The NBS phenotype includes a predisposition 
to cancer due to impaired DNA damage repair. Furthermore, we have shown that the addition of stimuli such 
as oxidative stress and mutagenic factors to this model could be used as a screening platform for anti-oxidants 
capable of suppressing DNA damage. Transcriptome analysis of our NBS-model identified de-regulation of P53, 
cell cycle, oxidative phosphorylation and glycolysis. In screening for antioxidants we identified EDHB as a potent 
modulator of DNA damage. Interestingly we revealed that NBS fibroblasts have a higher susceptibility for induc-
tion of DNA damage compared to NBS-iPSCs. However, although additional research is needed to improve the 
reprogramming efficiency and thus the robustness we believe that NBS-iPSCs can serve as cellular tools for a 
screening platform for molecules with anti-oxidant capabilities.
Methods
Ethical approval. NBS patient dermal fibroblast cells with informed consent (Table 1) were provided by 
Prof. Dr. Karl Sperling (Institute of Medical and Human Genetics, Charité - Universitätsmedizin Berlin, 13353 
Berlin). Approval was obtained from the Ethics Commission of the Charité—Universitätsmedizin. The methods 
and experimental protocols were carried out in accordance with their guidelines and regulations.
Cell culture. Neonatal foreskin fibroblasts, HFF1 and BJ were purchased from ATCC (#SCRC-1041 and 
#CRL-2522, respectively). All cells used were cultured at 37 °C, 5% CO2 and either 21% (standard) or 5% oxygen 
in an incubator under humidified atmosphere. Somatic cells were cultured in DMEM medium (Gibco, USA) sup-
plemented with 10% fetal bovine serum (FBS) and 1x penicillin/streptomycin until reaching 90% confluency and 
then split in a 1:4 ratio. The conditions for passaging human pluripotent stem cells (hPSC) were a combination of 
methods adapted from several published protocols61, 62. This was applied to the culture of the human ESC-lines 
H1 and H9 (WiCell Research Institute, Madison, WI, USA) and iPSCs generated from NBS and HFF1 cells. In 
combination with MEFs, hPSCs were usually cultivated in plates coated with 0,2% gelatin and fed with hESC 
medium containing KO-DMEM supplemented with 20% knockout serum replacement, non-essential amino 
acids, L-glutamine, penicillin/streptomycin, sodium pyruvate, 0.1 mM beta-mercaptoethanol and 4 ng/ml FGF-2, 
which was replaced every second day.
FACS analysis (detection of ROS and DNA damage). The FACSCalibur system (BD Biosciences, USA) 
and the software program CellQuestPro were used as described by the manufacturer’s instructions. Programs 
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used for data analysis were CellQuestPro (BD Biosciences, USA), Cyflogic (Cyflo Ltd, Finland), Weasel 3.0 
(WEHI, Australia) and Flowing software 2.5.1 (Finland) programs.
For ROS measurement, fibroblast cells were seeded onto 12-well-plates with a density of 5 × 104 cells per well 
one day prior to treatment. hESCs and iPSCs were seeded on Matrigel (Corning) in 6-well-plates and fed with 
hESC medium, one week prior to the treatment. To prepare cells for ROS-measurements, they were washed once 
with PBS and then incubated in 15 µM DCF-DA for 20 min at 37 °C. Afterwards, the solution was removed and 
the cells were briefly rinsed with PBS. Cells were treated with different concentrations of antioxidants (as indi-
cated) and/or 20 µM H2O2 for 30 min. To analyze single cells by FACS, they were trypsinized by colorless 0.05% 
trypsin solution for 5 min. Trypsinization was stopped by adding 10% FBS in PBS. Cells were then centrifuged 
by 500 × g for 5 min and re-suspended in 300 µl PBS. The fluorescence was measured by FACS using the FITC 
channel.
For measurement of DNA damage, fibroblast cells were seeded onto 6-well-plates with a density of 4 × 105 
cells per well one day prior to treatment. hESCs and iPSCs were seeded on Matrigel (Corning) in 6-well-plates 
and fed with hESC medium, one week prior to the treatment. Cells were either treated with antioxidants (as 
indicated) 5 min prior to the addition of 1 mM H2O2 or with H2O2 alone at a total incubation time of 4 h at 37 °C 
in a cell culture incubator with either 21% or 5% oxygen, as indicated. Other cells were treated with antioxidants 
(as indicated) 5 min prior to the addition of 30 µg/ml Bleomycin for 3 h, and released for 1 h by switching to 
Bleomycin-free medium. Afterwards, the cells were briefly rinsed with PBS and trypsinized to generate single 
cells. The cells were centrifuged at 500 × g for 5 min and the cell pellet was re-suspended in 100 µl PBS. Under 
constant shaking (to prevent clumping) 300 µl of 100% ice-cold ethanol was added dropwise to fix the cells and 
incubated at −20 °C for at least 30 min or until further use. Afterwards the solution was mixed with 1 ml PBS and 
centrifuged at 2200 × g for 5 min. The pellet was re-suspended in 50 ml PBS-T with 5% FBS and incubated 30 min 
at RT for blocking. FITC-labeled gamma-H2AX antibody (Millipore, 1:500) was added and incubated overnight 
at 4 °C. The next day, 300 µl PBS was added and the cells were measured by FACS using the FITC channel. In some 
cases, the cells were co-stained with TRA1-60 antibody (Santa Cruz Biotechnology, Inc.) to verify pluripotent cell 
populations.
Western Blot. The membrane was rinsed with dH2O and then blocked with 5% milk powder or 5% BSA 
in PBS-T (blocking solution) by shaking for 1 h at RT. BSA blocking solution was used for phospho-specific 
antibodies, in all other cases blocking was performed with milk. After blocking, the membrane was incubated 
by shaking at 4 °C overnight with the primary antibodies dissolved in PBS-T with 5% milk powder or 5% BSA; 
Beta-actin (Sigma-Aldrich), phospho-histone H2A.X (Ser139), phospho-CHEK1 and phospho-CHEK2 (CST), 
phospho-P53 (Ser15, CST), phospho-BRCA1 (Ser1524, CST), phospho-ATM (Ser1981, CST), phospho-ATR 
(Ser428, CST). Afterwards, the membrane was washed 3 times for 10 min in PBS-T on the Lab shaker, exchang-
ing buffer between each step. Then, the secondary antibody dissolved in milk or BSA blocking solution was 
applied by shaking for 1 h at RT. Afterwards the membrane was washed 3 times for 10 min in PBS-T. Appropriate 
peroxidase-conjugated secondary antibodies and luminescence was induced by ECL Plus Western Blotting 
Detection Reagents and captured on BioMAX XAR film.
Transcriptomics. The microarray hybridization experiments included biotin-labelling of cRNA by using 
500 ng quality-checked total RNA (per sample) as input. Chip hybridizations, washing, Cy3 streptavidin stain-
ing, and scanning were performed on BeadStation 500 platform (Illumina) using reagents and protocols sup-
plied by the manufacturer. cRNA samples were hybridized in duplicates on Illumina human-8 BeadChips 
(NBS-1, NBS-3, NBS-5, NBS-7, HFF1, BJ) or Illumina human-12 BeadChips (NBS-8, NBS-8 iPSCs, H1, H9 
(single), HFF1-iPSCs, BJ-iPSCs). Basic expression data analysis was carried out using the manufacturer’s soft-
ware GenomeStudio (Illumina). Raw data was background-subtracted and normalized using the “rank invariant” 
algorithm. Normalized data was then filtered for significant expression (detection p-value) based on negative 
control beads. All genes with detection p-values below 0.01 were considered as expressed. All genes with differ-
ential p-values below 0.05 were considered as differentially expressed. Selection for differentially expressed genes 
was performed on the basis of arbitrary thresholds (1.5 fold changes) and statistical significance according to an 
Illumina custom model63. Different sets of gene lists were entered into the DAVID functional annotation tool34, 
using the official gene symbol or ILLUMINA-IDs as input, to perform gene-annotation enrichment analysis, 
functional annotation clustering, KEGG pathway mapping (http://www.genome.jp/kegg/)36, transcription factor 
binding site prediction and more. Multiple testing was assessed via the Benjamini-Hochberg correction in the 
results of the DAVID analysis.
For the calculation of the activation state of transcription factors, a list of differentially regulated genes between 
NBS and normal fibroblasts was used as input for Ingenuity® Pathway Analysis (IPA®, QIAGEN Redwood City, 
www.qiagen.com/ingenuity).
Microarray data is available at NCBI GEO under the accession number GSE94708 for the superseries and 
GSE94706 for the fibroblasts and GSE94707 for the iPSCs series.
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